Netupitant/palonosetron in the Effective Management of Multiday Chemotherapy-induced Nausea and Vomiting

20 Sept 2024Oncology

Reema Subramanian

This content is sponsored. It is intended for healthcare professionals only.

Multiday chemotherapy is the mainstay treatment for many cancers. It has the advantage of increasing tolerability and maintaining dose intensity of combination chemotherapy agents.

MHK-FOS-2024019 Netupitant palonosetron in the Effective Management of Multiday Chemotherapy

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.